Windward Capital Management Co Ca Lowers stake in Mead Johnson Nutrition CO (MJN)

Mead Johnson Nutrition CO (MJN) : Windward Capital Management Co Ca reduced its stake in Mead Johnson Nutrition CO by 5.32% during the most recent quarter end. The investment management company now holds a total of 2,953 shares of Mead Johnson Nutrition CO which is valued at $239,075 after selling 166 shares in Mead Johnson Nutrition CO , the firm said in a disclosure report filed with the SEC on Oct 14, 2016.Mead Johnson Nutrition CO makes up approximately 0.05% of Windward Capital Management Co Ca’s portfolio.

Other Hedge Funds, Including , National Pension Service boosted its stake in MJN in the latest quarter, The investment management firm added 12,227 additional shares and now holds a total of 153,267 shares of Mead Johnson Nutrition CO which is valued at $12,408,496. Mead Johnson Nutrition CO makes up approx 0.10% of National Pension Service’s portfolio. Hexavest sold out all of its stake in MJN during the most recent quarter. The investment firm sold 515,718 shares of MJN which is valued $41,180,082. Genesee Valley Trust Co sold out all of its stake in MJN during the most recent quarter. The investment firm sold 3,602 shares of MJN which is valued $287,620.Atria Investments reduced its stake in MJN by selling 198 shares or 3.27% in the most recent quarter. The Hedge Fund company now holds 5,857 shares of MJN which is valued at $467,681. Mead Johnson Nutrition CO makes up approx 0.04% of Atria Investments’s portfolio.

Mead Johnson Nutrition CO opened for trading at $80.98 and hit $81.91 on the upside on Friday, eventually ending the session at $80.96, with a gain of 0.38% or 0.31 points. The heightened volatility saw the trading volume jump to 21,26,488 shares. Company has a market cap of $14,950 M.

On the company’s financial health, Mead Johnson Nutrition CO reported $0.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.78. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.

Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. CLSA Upgraded Mead Johnson Nutrition CO on Aug 3, 2016 to ” Outperform”, Price Target of the shares are set at $96.Mead Johnson Nutrition CO was Downgraded by Societe Generale to ” Hold” on Jul 29, 2016. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas children’s milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.

Leave a Reply

Mead Johnson Nutrition CO - Is it time to Sell?

Top Brokerage Firms are advising their investors on Mead Johnson Nutrition CO. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.